These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 8284377)
1. Ovarian masses: can benign and malignant lesions be differentiated with color and pulsed Doppler US? Brown DL; Frates MC; Laing FC; DiSalvo DN; Doubilet PM; Benson CB; Waitzkin ED; Muto MG Radiology; 1994 Feb; 190(2):333-6. PubMed ID: 8284377 [TBL] [Abstract][Full Text] [Related]
2. Colour and pulsed Doppler US and tumour marker CA 125 in differentiation between benign and malignant ovarian masses. Antonić J; Rakar S Anticancer Res; 1995; 15(4):1527-32. PubMed ID: 7654041 [TBL] [Abstract][Full Text] [Related]
3. Doppler sonography of adnexal masses: the predictive value of the pulsatility index in benign and malignant disease. Salem S; White LM; Lai J AJR Am J Roentgenol; 1994 Nov; 163(5):1147-50. PubMed ID: 7976891 [TBL] [Abstract][Full Text] [Related]
4. Validity of colour and pulsed Doppler US and tumour marker CA 125 in differentiation between benign and malignant ovarian masses. Antonić J; Rakar S Eur J Gynaecol Oncol; 1996; 17(1):29-35. PubMed ID: 8750512 [TBL] [Abstract][Full Text] [Related]
5. Differentiation of benign and malignant adnexal masses: relative value of gray-scale, color Doppler, and spectral Doppler sonography. Stein SM; Laifer-Narin S; Johnson MB; Roman LD; Muderspach LI; Tyszka JM; Ralls PW AJR Am J Roentgenol; 1995 Feb; 164(2):381-6. PubMed ID: 7839975 [TBL] [Abstract][Full Text] [Related]
6. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements. Czekierdowski A Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913 [TBL] [Abstract][Full Text] [Related]
7. [Doppler color-echo and flowmetric evaluations in ovarian tumors in postmenopausal patients]. de Albertis P; Serafini G; Cavallo A; Orio O; Gandolfo N; Quadri P Radiol Med; 1994 Apr; 87(4):488-92. PubMed ID: 8190933 [TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of adnexal masses with endovaginal gray-scale and duplex and color Doppler US: correlation with pathologic findings. Jain KA Radiology; 1994 Apr; 191(1):63-7. PubMed ID: 8134599 [TBL] [Abstract][Full Text] [Related]
9. Transvaginal color Doppler and CA125 as tools in the differential diagnosis of postmenopausal ovarian masses. Botsis D; Kassanos D; Kalogirou D; Karakitsos P; Liapis A; Antoniou G Maturitas; 1997 Apr; 26(3):203-9. PubMed ID: 9147352 [TBL] [Abstract][Full Text] [Related]
10. A critical analysis of Doppler velocimetry in the differential diagnosis of malignant and benign ovarian masses. Marchesini AC; Magrio FA; Berezowski AT; Neto OB; Nogueira AA; Candido dos Reis FJ J Womens Health (Larchmt); 2008; 17(1):97-102. PubMed ID: 18240986 [TBL] [Abstract][Full Text] [Related]
11. Power Doppler vascularity index for predicting malignancy of adnexal masses. Marret H; Sauget S; Giraudeau B; Body G; Tranquart F Ultrasound Obstet Gynecol; 2005 May; 25(5):508-13. PubMed ID: 15846763 [TBL] [Abstract][Full Text] [Related]
12. Color Doppler ultrasonography for prediction of malignant ovarian tumors. Benjapibal M; Sunsaneevitayakul P; Boriboonhirunsarn D; Sutanthavibul A; Chakorngowit M J Med Assoc Thai; 2002 Jun; 85(6):709-15. PubMed ID: 12322845 [TBL] [Abstract][Full Text] [Related]
13. Color Doppler ultrasound in the preoperative assessment of adnexal masses. Zanetta G; Vergani P; Lissoni A Acta Obstet Gynecol Scand; 1994 Sep; 73(8):637-41. PubMed ID: 7941989 [TBL] [Abstract][Full Text] [Related]
14. Transvaginal color Doppler sonography of adnexal masses: differences in blood flow impedance in benign and malignant lesions. Hamper UM; Sheth S; Abbas FM; Rosenshein NB; Aronson D; Kurman RJ AJR Am J Roentgenol; 1993 Jun; 160(6):1225-8. PubMed ID: 8498222 [TBL] [Abstract][Full Text] [Related]
15. [Color Doppler blood flow measurements and microvessel density assessment in ovarian tumors]. Czekierdowski A; Szymański M; Szumiło J; Kotarski J Ginekol Pol; 2003 Sep; 74(9):695-700. PubMed ID: 14674110 [TBL] [Abstract][Full Text] [Related]
16. Blood flow characteristics of ovarian tumors: implications for ovarian cancer screening. Carter JR; Lau M; Fowler JM; Carlson JW; Carson LF; Twiggs LB Am J Obstet Gynecol; 1995 Mar; 172(3):901-7. PubMed ID: 7892883 [TBL] [Abstract][Full Text] [Related]
17. Transvaginal color Doppler ultrasonic characterization of benign and malignant ovarian cystic teratomas and comparison with serum squamous cell carcinoma antigen. Emoto M; Obama H; Horiuchi S; Miyakawa T; Kawarabayashi T Cancer; 2000 May; 88(10):2298-304. PubMed ID: 10820352 [TBL] [Abstract][Full Text] [Related]
18. A comparison of intratumoural indices of blood flow velocity and impedance for the diagnosis of ovarian cancer. Tailor A; Jurkovic D; Bourne TH; Natucci M; Collins WP; Campbell S Ultrasound Med Biol; 1996; 22(7):837-43. PubMed ID: 8923703 [TBL] [Abstract][Full Text] [Related]
19. Benign and malignant ovarian masses: selection of the most discriminating gray-scale and Doppler sonographic features. Brown DL; Doubilet PM; Miller FH; Frates MC; Laing FC; DiSalvo DN; Benson CB; Lerner MH Radiology; 1998 Jul; 208(1):103-10. PubMed ID: 9646799 [TBL] [Abstract][Full Text] [Related]
20. [Preoperative determination of the structure of pelvic tumors with color-coded Doppler ultrasound and conventional transvaginal ultrasound diagnosis]. Leeners B; Funk A; Schild RL; Jörn H; Kemp B; Minkenberg R; Rath W Zentralbl Gynakol; 1998; 120(10):503-10. PubMed ID: 9823651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]